Articles from APA

Primary tabs

Single-Payer System Is the Solution for Mental Health Care, Panelists Say - AJMC.com Managed Markets Network

Submitted by Anonymous (not verified) on Mon, 05/07/2018 - 07:00

Single-Payer System Is the Solution for Mental Health Care, Panelists Say  AJMC.com Managed Markets NetworkIn a discussion during the American Psychiatric Association 2018 Annual Meeting, held in New York, New York, a panel of psychiatrists argued that private ...

Novel Buprenorphine Combination Therapy Shows Efficacy for MDD in Long-Term Trial - Psychiatry Advisor

Submitted by Anonymous (not verified) on Mon, 05/07/2018 - 07:00

Novel Buprenorphine Combination Therapy Shows Efficacy for MDD in Long-Term Trial  Psychiatry AdvisorNEW YORK — ALKS 5461, a novel treatment approach in major depressive disorder (MDD) consisting of a combination of buprenorphine (a μ-opioid receptor ...

Deutetrabenazine Associated With Long-Term Improvements for Tardive Dyskinesia - Psychiatry Advisor

Submitted by Anonymous (not verified) on Mon, 05/07/2018 - 07:00

Deutetrabenazine Associated With Long-Term Improvements for Tardive Dyskinesia  Psychiatry AdvisorAbnormal Involuntary Movement Scale scores were improved in both treatment groups with long-term deutetrabenazine treatment.

High Anxiety in America: APA Poll Highlights Nationwide Worries - Medscape

Submitted by Anonymous (not verified) on Mon, 05/07/2018 - 07:00

High Anxiety in America: APA Poll Highlights Nationwide Worries  MedscapeNEW YORK — Americans are much more anxious today than a year ago, and baby boomers have seen the largest increase in anxiety levels, according to a ...

Intranasal Esketamine Effective for Geriatric Patients With Treatment-Resistant Depression - Psychiatry Advisor

Submitted by Anonymous (not verified) on Mon, 05/07/2018 - 07:00

Intranasal Esketamine Effective for Geriatric Patients With Treatment-Resistant Depression  Psychiatry AdvisorNEW YORK — Almost twice as many geriatric patients with treatment-resistant depression showed a 50% response when treated with intranasal esketamine in ...

Deutetrabenazine Associated With Long-Term Improvements for Tardive Dyskinesia - Psychiatry Advisor

Submitted by Anonymous (not verified) on Mon, 05/07/2018 - 07:00

Deutetrabenazine Associated With Long-Term Improvements for Tardive Dyskinesia  Psychiatry AdvisorNEW YORK – Deutetrabenazine (DTB) is associated with long-term improvements in abnormal movements for patients with tardive dyskinesia, per the results of ...

Panelists Say Innovations in Digital Mental Health Care Increase Access and Deliver Positive Outcomes - AJMC.com Managed Markets Network

Submitted by Anonymous (not verified) on Mon, 05/07/2018 - 07:00

Panelists Say Innovations in Digital Mental Health Care Increase Access and Deliver Positive Outcomes  AJMC.com Managed Markets NetworkAt the American Psychiatric Association 2018 Annual Meeting, held in New York, New York, a panel addressed the role of digital innovation in delivering mental ...

Pharmacogenomic Testing Improves Outcomes in MDD Trial - Psych Congress Network

Submitted by Anonymous (not verified) on Mon, 05/07/2018 - 07:00

Pharmacogenomic Testing Improves Outcomes in MDD Trial  Psych Congress NetworkUsing pharmacogenomic testing to guide medication selection for patients with depression improved rates of response and remission, researchers reported.

Pages